To The Moon

$TSM VERTICAL 261030 PUT 415.0/PUT 420.0$ TSM is on very tight range, even today were most of the megacaps dip much lower. Taking this opportunity to add position.

TSM Vertical

09-24 00:12

US415.0/420.0

Side	Price \| Filled	Realized P&L
Credit Open	-1.23 3	-- Holding

TSM VERTICAL 261030 PUT 415.0/PUT 420.0

$TSM VERTICAL 261030 PUT 415.0/PUT 420.0$ TSM is on very tight range, even today were most of the megacaps dip much lower. Taking this opportunity ...

# Trade Feed: Who is your favorite trader?

TOPMosesMoses: Node lead still matters more to me here. TSM staying this tight while megacaps fade is the tell

1.00K

Report

12.10K

DKim

09-24

$Amazon.com(AMZN)$ Sold off some of the existing holding to get some profits off the table in view of the market volatility. This would also help to preserve my margin. The key objective is not to blow up the account and let the account lives to fight another day. The profits is determined when you entered the trade. And to exit to manage the risk. Will continue to monitor if I should sell off more...

AMZN

09-23 21:59

USAmazon.com

Side	Price	Realized P&L
Sell Close	250.40	+16.26% Closed

Amazon.com

$Amazon.com(AMZN)$ Sold off some of the existing holding to get some profits off the table in view of the market volatility. This would also help t...

# Trade Feed: Who is your favorite trader?

TOPWendyDelia: VIX staying elevated matters more to me here than the account angle. AMZN around 250 still feels tradable, but this tape can punish overstaying fast

1.01K

Report

3.12K

koolgal

09-24

🌟🌟🌟 $SanDisk Corp.(SNDK)$ is currently like a lightning rod. The structural need for memory is real, making a strong case for a supercycle. However the price you are paying for that future is heavily intoxicated by peak market sentiment. History screams a warning to those buying at the top. At these levels even a tiny piece of bad news, a minor shipping delay or a change in a single customer's budget could trigger a brutal avalanche. It is much better to buy $VanEck Semiconductor ETF(SMH)$ compared to buying just SanDisk alone. That way if SanDisk has a bad day, your portfolio is protected by othe

🌟🌟🌟 $SanDisk Corp.(SNDK)$ is currently like a lightning rod. The structural need for memory is real, making a strong case for a supercycle. However...

# The boss asked me to issue coins

TOP1PC: Nice Sharing 😁 @JC888 @Barcode @Shyon @Aqa @DiAngel @Shernice軒嬣 2000

482

Report

11.00K

TigerClub

09-24

🎤Samuel Wong: The Seller's Edge — A Practical Guide to Selling Cash-Secured Puts

Topic: From Options 101 to Order Execution ∙ Reading the Greeks and Moneyness ∙ Monitoring, Rolling and Surviving Liquidation Risk Speaker: Samuel Wong Samuel Wong, Investment Representative at Tiger Brokers (Singapore), walks through the cash-secured put strategy from first principles to live execution — including strike selection, order types, position monitoring, rolling, and the five most common mistakes he sees option sellers make. Samuel Wong is a trader with over 5 years of experience across market segments including precious metals and cryptocurrency, and 2 years of technical experience in financial derivatives ranging from US options and futures to SGX-listed DLCs. He also serves as an in-house trainer and speaker for Tiger Brokers, and as an Investment Representative for Tiger Br

🎤Samuel Wong: The Seller's Edge — A Practical Guide to Selling Cash-Secured Puts

TOPHe Man: Q1. I sell a put $125 on PLTR for 2028 Jan and collected $3000+ when price was $130+-. When rally the put drop to $200. I buy back and took almost $900+. Patience payoff over 30+ days. Q2. Sell a put for a share that drop 50% from IPO price but price keep dropping and was assigned the share. Dont feel like cutting loss and kept it as a learning reminder. While selling call to take rental. Too bad price still stay flat.

317

Report

1.64K

Shyon

09-24

For me, the biggest expectation is seeing how Greg Abel manages $Berkshire Hathaway(BRK.A)$ $Berkshire Hathaway(BRK.B)$ Berkshire’s huge capital base without losing the discipline that built the company. With around $365 billion in cash and Treasuries, capital allocation will be one of the key things I watch. My biggest concern is whether Berkshire can maintain the same level of shareholder trust without Warren Buffett making the major decisions. Abel’s recent moves give us some early clues, but the real test will be how consistently he allocates capital through different market cycles. Personally, I still see Berkshire as a long-term compounder rather than simply a “Buffett stock.” I will be watchin

Berkshire Hathaway’s Succession Milestone: What Investors Need to Know?

@AI_FocusedTrader：

$Berkshire Hathaway(BRK.A)$ / $Berkshire Hathaway(BRK.B)$ Disclaimer: This article is for informational purposes only and does not constitute investment advice. 💬 Discussion prompt: What is your biggest expectation or concern for Berkshire under its new dual‑track leadership? Share your views in the comments. Berkshire Hathaway has completed the final major step in its decades‑long leadership transition. Warren Buffett, 96, is stepping down as Chairman and moving to Chairman Emeritus, while his son Howard Buffett takes over the chair role. Greg Abel, who became Chief Executive Officer in January 2026, retains full operational authority over the $1.1‑trillion conglomerate.

Berkshire Hathaway’s Succession Milestone: What Investors Need to Know?

For me, the biggest expectation is seeing how Greg Abel manages $Berkshire Hathaway(BRK.A)$ $Berkshire Hathaway(BRK.B)$ Berkshire’s huge capital ba...

TOPriffy: The core test is whether Abel can deploy that cash pile above Treasury returns without loosening Berkshire's discipline. The next real tell is what he does in the next broad downturn.

169

Report

1.93K

Fistein

09-24

$IX Biopharma(42C.SI)$ 0.8 Target Price. --Ix Biopharama Medical Breakthrough-- iX Biopharma achieved a major medical and commercial breakthrough with Wafermine, its patented sublingual (under-the-tongue) ketamine wafer for non-opioid acute pain management. --The Core Technology-- WaferiXFast Absorption: Wafers dissolve sublingually in minutes, letting active ingredients enter the bloodstream directly and bypass the gut. High Bioavailability: Provides a needle-free, predictable alternative to intravenous infusions or standard oral pills. Drug Repurposing: Applies the delivery system to central nervous system agents and other urgent indications. --Key Pipeline & Commercial Milestones-- Backed by a US$40.95 million contract from the US Departm

$IX Biopharma(42C.SI)$ 0.8 Target Price. --Ix Biopharama Medical Breakthrough-- iX Biopharma achieved a major medical and commercial breakthrough w...

# 💰Stocks to watch today?(4 October）

TOPRalphWood: Phase 3 burn is the hard part here. That 40.95M contract sounds nice, but for a late-stage pain program it does not go that far lol

142

Report

1.96K

Shyon

09-24

For me, the biggest thing to watch is whether $Meta Platforms, Inc.(META)$ Muse can turn the initial download momentum into regular usage. Reaching No. 1 on the App Store is encouraging, but retention and daily usage will matter much more than launch-day excitement. I am also watching monetization closely. Meta already has massive distribution, so if Muse can eventually connect subscriptions, commerce and transactions, it could create a new revenue stream beyond advertising. But Amazon’s decision to block Muse also shows that platform access could become a major hurdle. Personally, I think the next phase is about proving the full cycle: adoption → retention → transactions → monetization. I would not judge Muse purely by the stock reaction yet.

For me, the biggest thing to watch is whether $Meta Platforms, Inc.(META)$ Muse can turn the initial download momentum into regular usage. Reaching...

TOPwigglyz: Apple or Google following Amazon would matter more than the launch rank. Distribution is Meta's edge, but platform gatekeeping could cap Muse way before monetization shows up.

134

Report

2.31K

Fistein

09-24

$IX Biopharma(42C.SI)$ 0.8 Target Price. --iX Biopharma Ltd(42C) Growth Catalysts-- Shift towards commercialisation of WaferiX subligual delivery of drugs could bump up revenue by as much as 250% in FY-2026, backed by planned capacity expansion. Out-licensing of the sublingual ketamine wafer, Wafermine, for Phase 3 development will be a major catalyst and expected to turn iX Biopharma profitable in long-term. Specialty pharmaceutical and nutraceutical drugs will benefit from the planned six-fold increase in production capacity to meet the expected surge in demand. Investment Merits Out-licensing world's first sublingual ketamine formula, Wafermine, for Phase 3 development is a near-term catalyst. Since the completion of its end-of-Phase 2 meetin

$IX Biopharma(42C.SI)$ 0.8 Target Price. --iX Biopharma Ltd(42C) Growth Catalysts-- Shift towards commercialisation of WaferiX subligual delivery o...

# 💰Stocks to watch today?(4 October）

TOPdoozi: Phase 3 is the whole bet here. Revenue math means little if Wafermine stalls at trial or licensing drags

Report

2.05K

nerdbull1669

09-24

Beyond the High: Market Breadth, AI’s Second Wave, and Tactical Options Strategies in the Nasdaq Surge

As the tech-heavy $NASDAQ(.IXIC)$ Nasdaq Composite breaches new record highs, a critical structural divergence has emerged under the market surface. While major capitalization benchmarks suggest robust equity health, participation metrics reveal a strikingly narrow advance: fewer than half of Nasdaq constituents trade above their 200-day moving average. In this article, we would like to go through these points on why Nasdaq breaches new record highs yet fewer than half of Nasdaq constituents trade above their 200-day moving average. Market Anatomy — Breakdown of index concentration, market breadth metrics (only ~48% of stocks above 200-day SMA), and structural divergence. Sectors, Stock Focus & AI Narrative — In-depth analysis of three convic

Beyond the High: Market Breadth, AI’s Second Wave, and Tactical Options Strategies in the Nasdaq Surge

# Nonfarm Payrolls Add Only 29K — Is the Rate-Hike Cycle Over?

TOPDrewStrong: That 48% above the 200-day is the part I care about more than the headline high. Cash-secured puts still work, but only if you respect how narrow this tape really is

Report

1.35K

Lanceljx

09-24

For the memory trade to stop needing the next price rise, I would want Micron to show that earnings growth can increasingly come from volume, product mix and structural AI demand rather than just higher DRAM and NAND prices. Strong HBM4 shipments, sustained data-centre demand, firm long-term customer commitments and continued margin strength even as pricing growth moderates would be especially important. If Micron can demonstrate that AI-driven memory demand remains ahead of supply into 2027 while volumes expand, the thesis becomes much more durable than simply betting on another pricing cycle.

For the memory trade to stop needing the next price rise, I would want Micron to show that earnings growth can increasingly come from volume, produ...

# Two-Thirds of Next Year's Capacity Already Sold — Who's Still Shorting Memory?

TOPchimey: HBM4 yield ramp and the timing of Nvidia's next platform matter more here than another DRAM leg up. If gross margin stays firm while bit shipments scale, the story gets a lot cleaner

Report

1.83K

Shyon

09-24

I am leaning toward the view that AI has strengthened the memory cycle, but it has not eliminated the cycle completely. HBM and server DRAM demand are structurally stronger because AI servers are consuming much more memory, so I think this upcycle can last longer than a traditional cycle. At the same time, I understand Burry’s argument. Strong pricing will attract more capacity, and if supply catches up with AI demand, memory margins can compress quickly. For me, the key risk is the timing of the supply response, especially from new capacity and improving technology. I am still constructive on $Micron Technology(MU)$ for the mid to long term, but I prefer watching pricing, inventory and supply data rather than simply following the bullish narrative

I am leaning toward the view that AI has strengthened the memory cycle, but it has not eliminated the cycle completely. HBM and server DRAM demand ...

# Two-Thirds of Next Year's Capacity Already Sold — Who's Still Shorting Memory?

TOPpangngk: HBM share is the missing piece here. Micron still needs cleaner progress on stack complexity and yields, and that probably matters more for margins than raw wafer capacity.

Report

2.09K

SGX_Stars

09-24

SGX Daily Top Movers (24-9-2026): D05, O39, U11, Z74, BS6, S63, C38U, S68, A17U & C6L lead

1.Top 10 Traded Stocks/ETF/SDR by Value $DBS(D05.SI)$ $OCBC Bank(O39.SI)$ $UOB(U11.SI)$ $Singtel(Z74.SI)$ $YZJ Shipbldg SGD(BS6.SI)$ $ST Engineering(S63.SI)$ $CapLand IntCom T(C38U.SI)$ $SGX(S68.SI)$ $CapLand Ascendas REIT(A17U.SI)$ $SIA(C6L.SI)$ 2.Stocks/ETF/SDR Hit 52-week High $YZJ Shipbldg SGD(BS6.SI)$

SGX Daily Top Movers (24-9-2026): D05, O39, U11, Z74, BS6, S63, C38U, S68, A17U & C6L lead

TOPfuzzyx: A17U making the 52-week low list stands out. For a REIT, yield still needs to clear the rate pressure properly. Is the dividend attractive enough here

Report

3.73K

koolgal

09-24

Catching China's Tech Dragons: Why the Amova E Fund ChiNext ETF Is The Ultimate High Growth Bet

🌟🌟🌟Are you tired of watching the global technology race from the sidelines or relying entirely on overextended Western tech giants trading at eye watering valuation premiums? While the crowd remains fixated on Silicon Valley, a quiet technological decoupling is taking place across Asia. $AmovaEFund ChiNext S$(CXT.SI)$ represents the literal engine room of China's next generation economy. Often dubbed as China's Nasdaq, this fund provides an asset light, direct gateway into the 100 most innovative, fast compounding growth titans listed on the Shenzhen Stock Exchange. It is a thrilling, high beta vehicle designed for investors ready to capture explosive alpha at a deep cyclical discount. Who Are The Fund Managers? Th

Catching China's Tech Dragons: Why the Amova E Fund ChiNext ETF Is The Ultimate High Growth Bet

# 💰Stocks to watch today?(4 October）

TOP1PC: Nice Sharing 😁 @DiAngel @JC888 @Barcode @Shyon @Aqa @Shernice軒嬣 2000

Report

840

DoTrading

09-24

Yields Roar, Equities Retreat

Wall Street spent Wednesday wrestling with a message the bond market is no longer whispering: yields are rising fast, and stocks can’t ignore it anymore. The session was broadly negative: $NASDAQ(.IXIC)$ : –1.13% $NVIDIA(NVDA)$ $Microsoft(MSFT)$ $Apple(AAPL)$ $S&P 500(.SPX)$ : –0.75% Dow: –0.68% Only energy managed to finish higher, as nearly every other sector buckled under the weight of surging rates. The trigger was a brutal 5‑year Treasury auction, as “disastrous.” Weak demand sent the 5‑year yield above 5%, its highest level since 2007. Long‑duration yields followed su

Yields Roar, Equities Retreat

Comment

Report

3.50K

TigerEvents

09-24

[Mid-Autumn Special] Reimagine Tiger with AI

This Mid-Autumn Festival, give Tiger a whole new look. We’re giving everyone the same Tiger image — your job is to reimagine it with AI. Take Tiger to a lantern festival, put it under the full moon, drop it into Singapore’s skyline, or send it all the way to the moon. Cute, cinematic, futuristic or completely wild — anything goes. How to join: Create an AI image using the following image, post your artwork, and add a short caption about your idea. If you don’t use AI tools, you can still join by dropping your idea in the comments — we may pick some concepts and create them for you. The best creations may win rewards and be featured by Tiger Community. Event Period: September 24–28, 2026 Rewards: Participation Reward: Everyone who joins the event and leaves a comment will receive 10 Tiger C

[Mid-Autumn Special] Reimagine Tiger with AI

# Tiger Friday

TOPkoolgal: 🌟There is a quiet yet profound beauty in the way the Moon connects us across space & time. Tonight, as the full moon reaches its brightest & most complete circle, millions of people look up at the exact same light, sharing an unspoken bond that has tied generations together for thousands of years. At its deepest heart, the Mid Autumn Festival is a celebration of the harvest of life - Family, Gratitude & the enduring power of Reunion. The Mooncake is far more than a sweet indulgent treat. It is a rich tapestry of meaning packed into a single pastry: Completeness: The roundness of the Mooncake mirrors the full Moon, representing Harmony, Unity & Family Love. Sharing: Slicing the Mooncake into wedges signifies that no matter how far we wander we are all part of the same whole. Golden Yolk: This represents the full moon - a beacon of Brightness & Prosperity. Wishing all my Tiger Friends Success & Prosperity & Growth😍🌈💰 @TigerEvents @TigerStars @Tiger_SG @Tiger_comments

Report

2.29K

Marktomarket

09-24

The 10-Year Hit Its Highest Since 2007. What Was Left Standing?

The indices: three directions the day before, one direction now All three indices closed lower on Wednesday: the $NASDAQ(.IXIC)$ Composite fell 1.13 per cent to 26,936.04, down 308.24 points on the day, giving back the record it had set in the previous session; the $S&P 500(.SPX)$ fell 0.75 per cent to 7,706.03, down 58.61 points; and the $Dow Jones(.DJI)$ fell 0.68 per cent to 51,511.59, down 352.10 points. The previous session had the three running separately — the Nasdaq closing at a record, the Dow lower, the S&P 500 finishing flat to within 0.06 points. A day later they were back on the same heading, a

The 10-Year Hit Its Highest Since 2007. What Was Left Standing?

# From Leaders to Laggards — Are Memory Stocks Waiting on Micron?

TOP靖润: All prices fell on Wednesday, not because the fundamentals collapsed, but because the discount rate jumped again. The 10-year yield rose to 5.11%, the highest since 2007, and all forward stories had to be discounted again. On Tuesday, the market was willing to pay for things that were "dated, termed, and verifiable," and on Wednesday, none of that changed—SanDisk's production capacity remained locked, NASA contracts were still signed, and Muse partners were still being added—but stock prices all fell. What changed wasn't the terms, but the rate. terms determine how much money the company can receive, and rate determines how much that money is worth today. On Wednesday, the rate overshadowed the terms. What memory stocks are waiting for right now isn't demand, but Micron's earnings report. Production capacity lockdowns, price increases, and HBM shortages—these terms are all there, and the market accepts them. However, once interest rates rise, these forward incomes will be returned at an even greater discount. Therefore, if Micron 9/30 can provide explosive guidance and profit margins, terms can outperform rate, and the valuation can expand again; If it's just "in line with expectations," rate will continue to ride on top. The same goes for Muse in Meta; they didn't say how much the commission was, so there's no way to calculate how much Muse is worth. Before this number, the rise was all about emotions. Now we just need to focus on two things: Micron's gross margin and guidance in its financial report, and whether Meta will announce Muse's transaction commission. Before these two numbers came out, all fluctuations were noise.

Report

8.45K

Capital_Insights

09-24

Bitcoin’s Bull Market Has Begun,Establishing a $250,000 Cycle Target by 2029

Bitcoin (, BUY) $Bitcoin(BTC.USD.CC)$ $Grayscale Bitcoin Mini Trust(BTC)$ $BTC Digital(BTCT)$ $Grayscale Bitcoin Trust(GBTC)$ - Bitcoin’s Bull Market Has Begun; Establishing a $250,000 Cycle Target by 2029 Tiger Research believe Bitcoin has entered a new bull-market regime and maintain BUY and establish a $250,000 cycle target to be reached by 2029 or earlier, implying approximately 190% upside from the latest price near $86,100. “Higher lows, higher highs and recovery above key investor cost bases support moving beyond our July late-bear-market assessm

Bitcoin’s Bull Market Has Begun,Establishing a $250,000 Cycle Target by 2029

TOP苏36: Bitcoin's bull case is becoming less about hype and more abouthow the market reacts to bad news. The Fed just hiked rates, the CLARITY Act stalled, and BTC still recovered towards $87K. More importantly, US spot Bitcoin ETFs recorded five straight inflow sessions, including nearly $999M on September 21. That tells us something important: buyers are increasingly willing to absorb macro and regulatory shocks. Tiger Research's $250K target by 2029 is therefore interesting not because $250K sounds exciting, but because its framework is based on Bitcoin's expanding monetary role, investor cost bases and its valuation relative to gold. But the key risk remains liquidity. If yields keep rising and ETF flows reverse, the bullish structure could be tested again. For me, the next question isn't "Can BTC reach $250K?" It'swhether Bitcoin can turn the $80K–$85K zone into long-term support. @Capital_Insights [贱笑]

Report

Most Discussed

7x24

All